CSA Expansive Agent Dosage for Shrinkage-Compensated Concrete
Why the Right Dosage Is a Trial Result, Not a Table Value
A CSA expansive agent works by forming ettringite to drive a controlled early expansion that offsets later drying shrinkage. The dosage that achieves this is narrow and system-specific: too little does not compensate, too much can be disruptive. This guide explains the mechanism, the factors that govern effective dosage, and how our product’s recommended dosage directions fit into shrinkage-compensated and post-cast strip design.
How Restrained Expansion Compensates Shrinkage
Shrinkage-compensated concrete does not eliminate shrinkage. It introduces a deliberate expansion first, so that the shrinkage which follows works against a pre-stored compression rather than pulling the concrete into tension. This is the principle behind expansive cement and expansive admixtures described in industry guidance such as ASTM C845 and ACI 223.
In a CSA-based system the sequence is straightforward. Soon after setting, ye’elimite reacts with the calcium sulfate source and water to precipitate ettringite. When this early expansion is restrained, typically by reinforcement or by the surrounding structure, it develops a mild compressive pre-stress in the concrete. As the element later dries and tries to contract, that contraction first relieves the stored compression instead of generating the tensile stress that causes cracking.
The word to hold onto is restrained. Free, unrestrained expansion does little useful work and can even be detrimental. Effective shrinkage compensation depends on the expansion being held back so it converts into pre-stress, which is why reinforcement ratio and restraint conditions matter as much as the dosage itself.
Why More Is Not Better
Expansion is a timing problem as much as a quantity problem. Three findings from the technical literature explain why dosage has to be tuned, not maximised.
An Optimum Exists
Studies of CSA expansive additives show compressive strength and dimensional performance improving up to an optimum dosage, then falling away. Beyond that point, extra expansive agent tends to give diminishing or negative returns rather than more benefit.
The Stiffness Window
Expansion has to do its work while the concrete is still young and its elastic modulus is low. As the modulus rises with age, the same expansion converts into less useful pre-stress, so the effective action happens in an early window rather than continuously.
Drying vs Autogenous
Expansive agents generally have a stronger effect on drying shrinkage than on autogenous shrinkage. This is why curing and moisture supply are part of the design, not an afterthought, and why one dosage cannot cover every shrinkage mechanism.
Factors That Govern Effective Dosage
Because the useful expansion is a balance struck early and then locked in by restraint, the effective dosage for a given project depends on more than a single number. The main variables are:
- Sulfate source and availability. Ettringite formation needs an adequate, appropriately reactive calcium sulfate supply. The sulfate balance in the base cement and admixture governs how much expansion the same dosage delivers.
- Water content and mix design. Water availability drives the reaction; a low water supply or rapid drying starves ettringite growth and reduces the expansion actually achieved.
- Cement system and compatibility. The behaviour differs between Portland-based and CSA-based systems and with the specific admixtures present, so dosage cannot be transferred unchanged between binders.
- Degree of restraint. Reinforcement ratio and boundary restraint decide how much of the expansion becomes useful pre-stress rather than lost free movement.
- Curing regime. Sustained moist curing during the early expansive period is essential; inadequate curing is one of the most common reasons a correctly dosed mix underperforms.
- Temperature. Ettringite is not stable at sustained elevated temperature, so hot conditions and hot-service applications need particular attention.
For all of these reasons, a published dosage range is a starting point for trial mixing, not a specification to be adopted directly.
Our CSA Expansive Agent: Dosage Directions
Typical values from supplied product information for our high-efficiency CSA expansive agent. Confirm by trial mix for your system.
| Item | Typical Value / Supplied Information |
|---|---|
| Product type | High-efficiency CSA expansive agent |
| Appearance | Grey-white powder |
| Specific gravity | 2.8 to 3.0 |
| Specific surface area | 250 to 400 m2/kg |
| Recommended dosage: shrinkage-compensating concrete | 6 to 8% of cementitious mass, subject to trial mix |
| Recommended dosage: post-poured (post-cast) strips | 9 to 10% of cementitious mass, subject to trial mix |
| Moist curing reminder | Not less than 14 days |
| Temperature reminder | Not recommended for continuous exposure above 80 °C |
| Restrained expansion grades | CSA-I / CSA-II / CSA-III direction |
Reading the Dosage Directions Correctly
The two dosage bands reflect two different jobs. The lower 6 to 8% range targets general shrinkage-compensated concrete, where the goal is to offset routine drying shrinkage under normal restraint. The higher 9 to 10% range is directed at post-poured strips, the closure pours between structural sections, where the surrounding hardened concrete imposes strong restraint and a larger compensating expansion is wanted.
Both bands carry the same qualifier: subject to trial mix. The optimum inside each band depends on the sulfate balance, cement system, restraint and curing of the actual project, and, as the literature shows, pushing above the optimum does not buy more performance. The 14-day moist-curing reminder and the 80 °C temperature limit are part of the same design logic, protecting the early ettringite expansion that the dosage is meant to produce.
Related Products
CSA Expansive Agent
Learn MoreCSA Cement
Learn MoreCSA Binder
Learn MoreDry Mix Mortar Premix
Learn MoreRelated Reading and Solutions
How CSA Expansive Agent Works
Read ArticleShrinkage Compensation in Dry Mix Mortar
Read ArticleShrinkage Compensation Solution
View SolutionTechnical Note
This article is intended for technical communication and product selection discussion. Recommended dosage directions are typical values from supplied product information and are subject to trial mix. Actual expansion and shrinkage-compensation performance depend on the sulfate source, cement system, water content, admixtures, degree of restraint, curing regime, temperature and application method. Trial mixing and local verification are required before commercial use, and design should follow the applicable standards and project specifications.
Dialling In an Expansive Agent Dosage?
Send us your cement system, target restraint and application (shrinkage-compensated concrete, post-cast strips, non-shrink grout or repair mortar), curing conditions and local raw materials. We can suggest a starting dosage direction and support trial mixing and sampling.
Send Your Inquiry